How is anesthesiology contributing to modern pain and mental health care?
Anesthesiology increasingly contributes to the care of complex pain and treatment-resistant mental health conditions by applying expertise in neurophysiology, pharmacology, and systems-level monitoring. This role extends beyond procedural care into multidisciplinary, longitudinal treatment models that address central nervous system dysregulation.¹
Traditionally, anesthesiology has focused on acute, time-limited interventions: perioperative anesthesia, procedural sedation, and critical care. Over the last decade, however, the specialty’s scope has expanded as neuroscience has clarified the shared mechanisms underlying chronic pain and certain psychiatric conditions.
This evolution reflects a broader shift in medicine away from siloed diagnoses and toward mechanism-informed care.
Why the Boundaries Between Pain and Mental Health Are Blurring
Chronic pain and mental health conditions have historically been treated as separate clinical domains. Increasingly, evidence suggests this distinction is incomplete.
Research over the past decade has demonstrated shared neurobiological mechanisms across chronic pain, depression, anxiety, and PTSD, including altered glutamatergic signaling, dysregulation of stress-response systems, and changes in cortical–limbic network connectivity.² ³ Central sensitization, once discussed primarily in pain medicine, is now recognized as relevant to emotional processing and mood regulation as well.⁴
Recent neuroimaging studies further support this overlap, showing that persistent pain and mood disorders involve common alterations in brain regions responsible for salience, affect, and threat perception.⁵
What Anesthesiology Brings to These Clinical Questions
Anesthesiologists are trained to manage medications and interventions that directly affect consciousness, perception, and autonomic regulation. This training is particularly relevant in conditions involving complex nervous system dysregulation.
Key competencies include:
- Expertise in NMDA receptor modulation and glutamatergic signaling
- Experience titrating centrally acting medications with narrow therapeutic windows
- Rigorous attention to physiologic monitoring and safety
- Familiarity with high-acuity, high-risk clinical environments
These skills translate naturally to emerging treatment models that require individualized dosing, close monitoring, and careful integration into broader care plans.
Ketamine as an Example—Not a Panacea
Ketamine illustrates how anesthesiology-informed approaches have entered both pain management and psychiatry.
Over the last ten years, and particularly within the last five, randomized trials and systematic reviews have supported ketamine’s potential role in:
- Treatment-resistant depression⁶ ⁷
- Certain chronic and neuropathic pain conditions⁸ ⁹
Ketamine’s primary mechanism—NMDA receptor antagonism with downstream effects on synaptic plasticity—has been associated with rapid symptom reduction in select patients.¹⁰ Importantly, these effects are variable, time-limited, and dependent on careful patient selection and clinical context.
Ketamine is not curative and is not appropriate for all patients. Its clinical value lies in its ability to modulate central nervous system activity in ways that may reduce symptom burden and allow patients to engage more effectively with other therapies.
From Isolated Interventions to Integrated Care Models
Contemporary anesthesiology-led ketamine programs increasingly emphasize longitudinal, collaborative care rather than isolated interventions.
Consensus statements and clinical guidelines now stress:
- Thorough screening and risk assessment
- Individualized dosing strategies
- Ongoing reassessment of benefit and appropriateness
- Coordination with referring providers and existing care teams¹¹
This approach mirrors broader trends in pain medicine and psychiatry, where durable improvement is understood to depend on multimodal, coordinated treatment rather than single-intervention solutions.
Why This Evolution Matters
For clinicians, the expanding role of anesthesiology reflects a shift toward mechanism-based treatment models that better align with current neuroscience.
For patients, it offers access to physicians trained to work safely with powerful medications while maintaining clear boundaries, realistic expectations, and a commitment to evidence-based care.
As medicine continues to grapple with the complexity of chronic pain and mental health conditions, anesthesiology’s contribution lies not in replacing other specialties, but in helping build responsible, integrated systems of care.
References
- American Society of Anesthesiologists | https://www.asahq.org/advocating-for-you/guidance/ketamine-safe-use
- Cohen SP, Vase L, Hooten WM | https://www.thelancet.com/article/S0140-6736%2821%2900393-7/fulltext
- Krystal JH et al. | https://pmc.ncbi.nlm.nih.gov/articles/PMC2898127/
- Woolf CJ | https://pmc.ncbi.nlm.nih.gov/articles/PMC3268359/
- Martucci KT, Mackey SC | https://pmc.ncbi.nlm.nih.gov/articles/PMC5953782/
- Schwartz J, Murrough JW, Iosifescu DV | https://pmc.ncbi.nlm.nih.gov/articles/PMC10699412/
- Bahji A et al. | https://pmc.ncbi.nlm.nih.gov/articles/PMC7704936/
- Cohen SP et al. | https://pmc.ncbi.nlm.nih.gov/articles/PMC6023575/
- Niesters M et al. | https://pmc.ncbi.nlm.nih.gov/articles/PMC4014022/
- Zanos P et al. | https://pmc.ncbi.nlm.nih.gov/articles/PMC6020109/
- Sanacora G et al. | https://pubmed.ncbi.nlm.nih.gov/28249076/
